Skip to main content
Erschienen in: Heart Failure Reviews 4/2016

20.04.2016

Thyroid hormones and heart failure

verfasst von: Felipe Martinez

Erschienen in: Heart Failure Reviews | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Heart failure is a major health problem and its relationship to thyroid dysfunction has been increasingly investigated in recent years. Since it has been demonstrated that thyroid hormones (TH) and mainly T3 have cardioprotective effects, it is easy to understand that in the scenario of thyroid disorder, cardiac function may be damaged, and inversely in cardiac dysfunction thyroid dysregulation may be seen. The increase in plasma TH produces a clear neurohormonal activation which impacts negatively on cardiac function. In hypothyroidism, and in addition to extracardiac dysfunction, myocardial and vascular remodelling is altered and they contribute to cardiac failure. Abnormal low plasma TSH has also been shown to be a risk factor for developing HF in several recent studies, and they suggest that TSH is an independent predictor of clinical outcome including death and cardiac hospitalizations. Therefore, physicians should consider all these concepts when managing a patient with heart failure, not only for a clear diagnosis, but also for better and accurate treatment.
Literatur
1.
Zurück zum Zitat Konstam MA (2000) Progress in heart failure management? Lessons from the real world. Circulation 102:1076–1078CrossRefPubMed Konstam MA (2000) Progress in heart failure management? Lessons from the real world. Circulation 102:1076–1078CrossRefPubMed
2.
4.
Zurück zum Zitat Vicinanza R, Cappotelli G, Malacrino C, Nardo T, Buchetti B, Lenti L et al (2013) Oxidized low density liporoteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells. Thyroid 23:231–238CrossRefPubMedPubMedCentral Vicinanza R, Cappotelli G, Malacrino C, Nardo T, Buchetti B, Lenti L et al (2013) Oxidized low density liporoteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells. Thyroid 23:231–238CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Schmidt Ott UM, Acheim DD (2006) Thyroid hormone and heart failure. Cuur Heart Fail Rep 3:114–119CrossRef Schmidt Ott UM, Acheim DD (2006) Thyroid hormone and heart failure. Cuur Heart Fail Rep 3:114–119CrossRef
6.
Zurück zum Zitat Bauer DC (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466CrossRefPubMed Bauer DC (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466CrossRefPubMed
7.
Zurück zum Zitat Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP et al (2008) Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure: the Cardiovascular Health Study. J Am Coll Cardiol 52:1152–1159CrossRefPubMedPubMedCentral Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP et al (2008) Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure: the Cardiovascular Health Study. J Am Coll Cardiol 52:1152–1159CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR et al (2012) Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126:1040–1049CrossRefPubMed Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR et al (2012) Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126:1040–1049CrossRefPubMed
9.
Zurück zum Zitat Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for aterosclerosis and myocardial infarction in elderly women. The Rotterdam study. Ann Intern Med 132:270–278CrossRefPubMed Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for aterosclerosis and myocardial infarction in elderly women. The Rotterdam study. Ann Intern Med 132:270–278CrossRefPubMed
10.
Zurück zum Zitat Chen S, Shauer A, Zwas DR, Lotan C, Keren A, Gotsman I (2014) The effect of thyroid function on clinical outcome in patients with heart failure. Eur J Heart Fail 16:217–226CrossRefPubMed Chen S, Shauer A, Zwas DR, Lotan C, Keren A, Gotsman I (2014) The effect of thyroid function on clinical outcome in patients with heart failure. Eur J Heart Fail 16:217–226CrossRefPubMed
11.
Zurück zum Zitat Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Johnson GW, Poole JE et al (2013) Thyroid function in heart failure and impact on mortality. JACC Heart Fail 1:48–55CrossRefPubMedPubMedCentral Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Johnson GW, Poole JE et al (2013) Thyroid function in heart failure and impact on mortality. JACC Heart Fail 1:48–55CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M et al (2003) Low-T3 syndrome. A strong prognostic predictor of death in patients with heart disease. Circulation 107:708–713CrossRefPubMed Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M et al (2003) Low-T3 syndrome. A strong prognostic predictor of death in patients with heart disease. Circulation 107:708–713CrossRefPubMed
13.
Zurück zum Zitat Pingitore A, Landi P, Taddei MC, Ripoli A, L’Abbate A, Iervasi G (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118:132–136CrossRefPubMed Pingitore A, Landi P, Taddei MC, Ripoli A, L’Abbate A, Iervasi G (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118:132–136CrossRefPubMed
14.
Zurück zum Zitat Pimentel RC, Cardoso GP, Escosteguy CC, Abreu LM (2006) Thyroid hormone profile in acute coronary syndromes. Arq Bras Cardiol 87:688–694PubMed Pimentel RC, Cardoso GP, Escosteguy CC, Abreu LM (2006) Thyroid hormone profile in acute coronary syndromes. Arq Bras Cardiol 87:688–694PubMed
15.
Zurück zum Zitat Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P et al (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172:799–809CrossRefPubMed Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P et al (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172:799–809CrossRefPubMed
16.
Zurück zum Zitat Laragh JH, Sealey JE (2003) Relevance of the plasma renin control system that regulates blood pressure and sodium level for correcting treating hypertension and ALLHAT. Am J Hypertens 16(407):411 Laragh JH, Sealey JE (2003) Relevance of the plasma renin control system that regulates blood pressure and sodium level for correcting treating hypertension and ALLHAT. Am J Hypertens 16(407):411
18.
Zurück zum Zitat Bamashmoos L, Al-Nuzaily B, Al-Meeri A, Ali F (2013) Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. SpringerPlus 2:423CrossRefPubMedPubMedCentral Bamashmoos L, Al-Nuzaily B, Al-Meeri A, Ali F (2013) Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. SpringerPlus 2:423CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersi WM (2001) Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol 54:197–204CrossRef Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersi WM (2001) Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol 54:197–204CrossRef
20.
Zurück zum Zitat Deveroux D, Teweld SZ (2014) Endocrine and metabolic emergencies. Hypertiroydism and thyrotoxicosis. Emerg Med Clin North Am 32(2):VII–X Deveroux D, Teweld SZ (2014) Endocrine and metabolic emergencies. Hypertiroydism and thyrotoxicosis. Emerg Med Clin North Am 32(2):VII–X
21.
Zurück zum Zitat Yamashita Y, Iguchi M, Nakatani R, Usui T, Takagi D, Hamatani Y et al (2015) Thyroid storm with heart failure treated with a short-acting beta-adrenoreceptor blocker, landiolol hydrochloride. Intern Med 54:1633–1637CrossRefPubMed Yamashita Y, Iguchi M, Nakatani R, Usui T, Takagi D, Hamatani Y et al (2015) Thyroid storm with heart failure treated with a short-acting beta-adrenoreceptor blocker, landiolol hydrochloride. Intern Med 54:1633–1637CrossRefPubMed
22.
Zurück zum Zitat Gerdes AM, Iervasi G (2010) Thyroid replacement therapy and heart failure. Circulation 122:385–393CrossRefPubMed Gerdes AM, Iervasi G (2010) Thyroid replacement therapy and heart failure. Circulation 122:385–393CrossRefPubMed
23.
Zurück zum Zitat Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D et al (2008) Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 93:1351–1358CrossRefPubMed Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D et al (2008) Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 93:1351–1358CrossRefPubMed
24.
Zurück zum Zitat Pantos C, Mourouzis I, Cokkinos DV (2011) New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev 16(1):79–96CrossRefPubMed Pantos C, Mourouzis I, Cokkinos DV (2011) New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev 16(1):79–96CrossRefPubMed
25.
Zurück zum Zitat Cokkinos DV (2014) The mechanisms of cell death. In: Cokkinos DV (ed) Introduction to translational cardiovascular research. Springer, Cham, pp 253–278 Cokkinos DV (2014) The mechanisms of cell death. In: Cokkinos DV (ed) Introduction to translational cardiovascular research. Springer, Cham, pp 253–278
Metadaten
Titel
Thyroid hormones and heart failure
verfasst von
Felipe Martinez
Publikationsdatum
20.04.2016
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 4/2016
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-016-9556-5

Weitere Artikel der Ausgabe 4/2016

Heart Failure Reviews 4/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.